Fred Hutch licenses new immunotherapy treatment to Mustang Bio, preps clinical trials in Seattle by Clare McGrane on September 14, 2017September 14, 2017 at 9:58 am A new immunotherapy technology developed at Seattle’s Fred Hutchinson Cancer Research Center has been licensed to New York-based Mustang Bio, a subsidiary of Fortress Biotech. The technology is the basis… Read More